Minimal Change Disease: Understanding Your Pathology Report

By Jason Wasserman MD PhD FRCPC
July 21, 2026

Minimal change disease is a kidney condition that causes large amounts of protein to leak into the urine. Its name comes from the way it looks under an ordinary microscope: the kidney appears essentially normal, with only minimal or no visible change. The real abnormality is invisible at that level and can be seen only with a much more powerful electron microscope, which reveals damage to specialized filtering cells called podocytes. It is the most common cause of a condition called nephrotic syndrome in children, and it also occurs in adults.

Because the kidney looks nearly normal under the ordinary microscope, a pathology report for minimal change disease can be confusing: it may describe the glomeruli as normal or unremarkable, even though a serious leak of protein is occurring. This article will help you understand the findings in your pathology report for minimal change disease, what each term means, and why the diagnosis depends so heavily on the electron microscope. Because this condition is especially common in children, this article is written for parents and caregivers as well as for adult patients.

What do the kidneys do?

The kidneys filter the blood, removing waste and extra water as urine while keeping useful substances in the body. The filtering happens in millions of tiny units called nephrons. At the start of each nephron is a cluster of small blood vessels called a glomerulus (the plural is glomeruli), which works like a sieve. Wrapped around the outside of this sieve are specialized cells called podocytes, whose interlocking “foot processes” form the final barrier that keeps protein in the blood. Minimal change disease is a disease of these podocytes: when their foot processes are damaged, the barrier fails and protein escapes into the urine. This is why podocytes and their foot processes are central to the diagnosis.

What causes minimal change disease?

In most people, the cause of minimal change disease is unknown; this is called primary or idiopathic disease. It is thought to involve the immune system: a signal from immune cells is believed to injure the podocytes and cause their foot processes to flatten, which lets protein leak through. Research continues into the exact trigger, and one recent line of work points to specific antibodies against a podocyte protein called nephrin in some people.

Less often, minimal change disease is secondary, meaning it is set off by something identifiable. Recognized triggers include certain medications (such as some anti-inflammatory drugs), some infections, allergies, and, rarely, certain cancers, particularly lymphomas. When a secondary cause is present, treating or removing it is part of managing the kidney disease. In children, the disease is almost always primary, while in adults a secondary cause is looked for more carefully.

Who gets minimal change disease?

Minimal change disease is primarily a disease of children. It causes the large majority of nephrotic syndrome in young children, most often between the ages of about 1 and 10, and is somewhat more common in boys. It occurs in adults as well, where it causes a smaller share of nephrotic syndrome, and it can appear at any age.

What are the symptoms of minimal change disease?

The symptoms of minimal change disease come from protein leaking out of the blood and into the urine, and they can appear quite suddenly. They may include:

Swelling (edema), often noticed first around the eyes in the morning, and in the legs, ankles, and abdomen. In children, puffiness around the eyes is frequently the first sign a parent notices.
Foamy or bubbly urine, from the protein.
Weight gain from retained fluid.
Reduced urine output.

This combination of heavy protein loss in the urine, low protein levels in the blood, and swelling is called nephrotic syndrome. In minimal change disease, it often develops rapidly, over days to a couple of weeks, and children can appear quite swollen while otherwise feeling relatively well.

How is the diagnosis made?

How minimal change disease is diagnosed depends on the patient’s age, and this is one of the most important things to understand about it.

In children, minimal change disease is so overwhelmingly the cause of nephrotic syndrome that a biopsy is usually not done at first. Instead, a child with the typical picture is treated with a course of corticosteroids, and a rapid response strongly confirms the diagnosis without ever needing to examine kidney tissue. A biopsy is reserved for children who do not respond to steroids, or whose presentation is unusual in some way, because those situations raise the possibility of a different kidney disease. In adults, by contrast, nephrotic syndrome has many possible causes, so a kidney biopsy is generally performed before treatment to establish the diagnosis.

When a biopsy is done, a pathologist examines the tissue in three ways, and the result is the defining feature of this disease: the first two look normal, and only the third shows the problem.

Light microscopy — Under an ordinary microscope, the glomeruli look normal or nearly normal. This is the “minimal change” the disease is named for. A report describing the glomeruli as normal or unremarkable is not a mistake or an oversight; a normal appearance here is exactly what is expected.
Immunofluorescence — This test, which detects deposited proteins and antibodies, is typically negative in minimal change disease. Its main value is to rule out other kidney diseases, which usually do show deposits.
Electron microscopy — This is where the diagnosis is made. Under very high magnification, the podocyte foot processes, normally standing apart like the teeth of a comb, are seen to have flattened out and merged together, a change called foot process effacement. This widespread effacement, in a kidney that otherwise looks normal, is the hallmark of minimal change disease.

Understanding this pattern explains why the electron microscope is essential here, whereas in many other kidney diseases the diagnosis can be made under an ordinary microscope. In minimal change disease, the ordinary microscope shows nothing, and the whole diagnosis rests on the podocyte change visible only by electron microscopy.

The relationship with FSGS

Minimal change disease is closely related to another kidney disease called focal segmental glomerulosclerosis (FSGS), and the two are considered part of a spectrum of podocyte disease. Both involve injury to the podocytes, and both cause heavy protein loss. The difference is that FSGS also shows scarring in part of some glomeruli under the ordinary microscope, while minimal change disease shows none.

This relationship has a practical consequence. Because FSGS scarring can be patchy and easy to miss in a small biopsy sample, a biopsy that looks like minimal change disease occasionally turns out to be FSGS once more tissue is examined, or a repeat biopsy is done, particularly when the disease does not respond to steroids as expected. For this reason, minimal change disease that behaves unusually, especially one that resists treatment, is sometimes re-examined with FSGS in mind. If your care team mentions this possibility, it reflects the close relationship between the two conditions rather than a change in your diagnosis.

What is the outlook?

The outlook for minimal change disease is generally very good, especially in children, and it is one of the more treatable kidney diseases. Most people, and the great majority of children, respond well to initial treatment, with the protein leak resolving and kidney function preserved. Unlike many kidney diseases, minimal change disease usually does not cause permanent scarring or lead to kidney failure when it responds to treatment.

The main challenge is not permanent damage but relapse: the protein leak can return, sometimes more than once, and some people have several relapses over time. This is more common in children, though children also tend to outgrow the tendency as they get older. People whose disease relapses frequently, or who depend on continued treatment to stay in remission, may need longer or additional therapy, but even then the long-term outlook for kidney function remains favorable in most cases. During a relapse, while protein levels are high, there is a temporary increased risk of infections and of blood clots, which is one reason flares are monitored and treated promptly.

What happens after the diagnosis?

Minimal change disease is managed by a kidney specialist (a nephrologist), and for children, a pediatric kidney team. Treatment aims to stop the protein leak and, when relapses occur, keep the disease in remission. This is a general overview; the specific plan is individual, and this article does not recommend any particular treatment.

Corticosteroids — Steroids are the main first treatment and are highly effective, especially in children, where the protein leak often resolves within days to weeks. In adults, the response is usually good as well but can take longer.
Treatment for frequent relapses or steroid dependence — Some people relapse repeatedly or can only stay in remission while on steroids. To reduce the long-term use of steroids and their side effects, other medications may be used, including calcineurin inhibitors, mycophenolate, cyclophosphamide, or rituximab, a drug that depletes certain immune cells. The choice depends on age, how the disease is behaving, and other health factors.
Supportive care — While protein loss is heavy, measures such as reducing salt, managing fluid, and sometimes medications to lower protein in the urine or prevent complications are used alongside the main treatment. Because of the temporary risk of infection and blood clots during a relapse, these are watched for.
Looking for a secondary cause — In adults especially, the team considers whether a medication, infection, or other condition might be responsible, since addressing it is part of treatment.
Monitoring — Protein in the urine is followed closely, often with simple home or clinic urine tests, so that relapses are caught early. Kidney function is checked over time, and treatment is adjusted based on how the disease behaves.

Questions to ask your doctor

Was my diagnosis (or my child’s) made from a biopsy, or from the response to treatment?
If a biopsy was done, did the electron microscopy confirm foot process effacement?
Is there any sign this could be FSGS rather than minimal change disease?
Could a medication, infection, or other condition have triggered this?
How much protein is in the urine, and what are we aiming for?
What treatment do you recommend, and how quickly should it work?
How likely is a relapse, and how will we watch for one?
If relapses happen, what are the options beyond steroids?
How can I monitor for a relapse at home?
Are there precautions I should take during a relapse, such as for infection?
What is the long-term outlook for kidney function?
What signs should prompt me to contact the care team?